Virax Biolabs Group Limited filed its 20-F on Jun 14, 2023 for the period ending Mar 31, 2023. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.06 USD | +1.92% | +17.78% | -27.40% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-27.40% | 2.46M | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- VRAX Stock
- News Virax Biolabs Group Limited
- Virax Biolabs Group Limited Auditor Raises 'Going Concern' Doubt